{"url":"https://lda.senate.gov/api/v1/filings/c85a89dd-e89d-4f25-bd6a-b5a9ff4183b7/","filing_uuid":"c85a89dd-e89d-4f25-bd6a-b5a9ff4183b7","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2024,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/c85a89dd-e89d-4f25-bd6a-b5a9ff4183b7/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Stacey Barrack","dt_posted":"2024-07-22T10:44:18-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"915 L Street NW #1006","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401105944,"url":"https://lda.senate.gov/api/v1/registrants/401105944/","house_registrant_id":null,"name":"STACEY BARRACK D/B/A STACEY BARRACK","description":"Consulting","address_1":"915 L Street NW #1006","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STACEY BARRACK","contact_telephone":"+1 202-559-9327","dt_updated":"2026-07-22T12:45:31.527701-04:00"},"client":{"id":208737,"url":"https://lda.senate.gov/api/v1/clients/208737/","client_id":12,"name":"VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES","general_description":"Public health advocacy for safe prescription medicines.","client_government_entity":false,"client_self_select":null,"state":"OH","state_display":"Ohio","country":"US","country_display":"United States of America","ppb_state":"OH","ppb_state_display":"Ohio","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-02-15"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to counterfeit medicines and products; drug pricing; prescription drug importation from Canada and other foreign countries, PBM Reform and Accountability; prescription drug supply chain safety","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":93594,"prefix":null,"prefix_display":null,"first_name":"STACEY","nickname":null,"middle_name":null,"last_name":"BARRACK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}